Actively Recruiting
The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery
Led by Singapore Eye Research Institute · Updated on 2025-01-29
120
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this research is to investigate the effects of ripasudil administered as an ophthalmic solution in patients with FED after femtosecond laser assisted cataract surgery. The secondary aim is to identity the characteristics of patients who will benefit the most with the use of ripasudil based on the test results obtained from this study.
CONDITIONS
Official Title
The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with Fuchs' Endothelial Dystrophy who are scheduled for cataract surgery
- Age over 50 years
- Ability to provide informed consent and sign a written consent form
- Willingness and ability to return for follow-up visits up to 12 months after surgery
You will not qualify if you...
- Unable to give consent
- Having only one functioning eye due to loss of vision in the other eye
- Presence of other serious eye diseases that could affect the study
- Previous use of ripasudil
- History of cardiovascular or kidney disease
- Known allergies to components of Glanatec Ophthalmic Solution 0.4%
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Singapore National Eye Centre
Singapore, Singapore, Singapore, 168751
Actively Recruiting
Research Team
M
Marcus Ang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here